Hi {{ first name | there }} 👋
As we age, our health needs evolve - and this tech is evolving with us. This week’s HealthHack Newsletter is focused on the tools that help us sleep better, detect illness earlier, and manage chronic conditions from the comfort of home.
From new ways to monitor glucose and vital signs, to promising breakthroughs in cancer and Alzheimer’s care, every story here points to a future of more dignified, personalized care.
The HealthHack Newsletter reaches over 40,000 engaged readers around the world. If you’d like to see your breakthrough featured or your message shared, reach out to us at [email protected].
Poll of the Week 🗳
EDITOR’S CHOICE ✨
The Sleep Study Comes Home
Clinical-grade sleep monitoring has long required a night in a lab. Undae Science wants to change that with Noctae, a non-contact device that slides under your sheet, not under your skin. It captures AI-powered sleep diagnostics from home - over multiple nights - so doctors get a fuller picture, faster.
Better yet? It may help prevent chronic diseases linked to poor sleep, like cardiovascular conditions and depression. If you've been putting off a sleep checkup, the wait might soon be over.
Chronic Care, Reimagined
Men’s Health Goes Global
From ED to acne, Fellos is breaking the silence around common but often-ignored male health issues. With digital GP consults and discreet medication delivery, it’s removing stigma and adding convenience. Already treating over 10,000 users, the platform’s next step: expanding into more care areas -and closing the digital health gap for men.
Remote Care That Sticks
RDS’s MultiSense patch tracks vital signs continuously -even after hospital discharge. Designed for reuse and industrial scale-up, it’s a sustainability-minded solution for post-op monitoring, short stays, and chronic care alike. Already live in 15 hospitals, it’s gaining traction.
Life-Changing Interventions
A Trojan Horse for Tumors
Trogenix is targeting the uncrackable: glioblastoma and metastatic colorectal cancer. Its gene therapy platform sneaks past the immune system with AAV vectors, activates a tumor-killing response, and even has a backup plan to prevent recurrence. With trials set for 2026, it’s a leap toward “one-and-done” cancer cures.
Infertility, Rethought
Half of all infertility cases involve men - and yet treatments often overlook them. Igyxos aims to fix that. Its antibody-based drug enhances follicle-stimulating hormone (FSH) activity in both men and women. If Phase 2 trials confirm early promise, we could see a dual-sex breakthrough for couples facing fertility challenges.
VISIONARY VOICES 💬
Robotic Dexterity, Handheld Simplicity
Panda Surgical is shrinking the robot - literally. Its 3mm wristed instruments fit into a handheld platform that brings robotic precision to complex neurosurgery without the bulk or learning curve.
Developed out of UCL, it could democratize brain and spine surgery by making it more intuitive, accessible, and safe. First-in-human trials are up next.
Next-Gen Neuro & Imaging
Advances for Alzheimer’s and Parkinson’s
Aerska is developing systemically delivered RNAi medicines for the brain - something long thought out of reach due to the blood-brain barrier. Its antibody-oligo conjugates (AOCs) act like “brain shuttles,” allowing precise gene silencing in conditions like Alzheimer’s and Parkinson’s.
Portable MRI, No Compromises
Multiwave’s MGNTQ is a portable MRI scanner aiming to make brain imaging more accessible and affordable. Designed for point-of-care use and easier deployment, it could dramatically cut wait times and costs - especially in underserved regions. FDA clearance is underway, with commercial rollout expected in 2026.
AI in Action
A Weight Loss Coach That Texts Back
Simple Life’s AI health coach, Avo, delivers nutrition advice and weight-loss guidance with just the right level of digital cheerleading. Recognized for its evidence-backed approach, the platform personalizes every step without calorie-counting micromanagement. With over 800,000 active subscribers, Simple is proving that sustainable results come from adaptive AI - not one-size-fits-all rules.
Glucose Insights in Real Time
Clear.bio’s app pairs real-time glucose monitoring with customized food advice to help users reverse Type 2 diabetes without meds. With CE-marking and new reimbursement pathways in sight, this Dutch platform could help Europe’s 70 million diabetes patients regain control - one snack at a time.
Well that’s it! 🚀
From real-time glucose tracking to brain-targeting gene therapies, this issue was packed with tools aimed at preserving health and independence in life. As always, our goal at the HealthHack Newsletter is to help you stay ahead of what’s possible - and what’s coming next.
If you’ve got feedback, ideas, or something worth featuring, we’d love to hear from you.
Your HealthHack Team